The global pharmacy automation devices market was valued at USD 4.82 billion in 2020 and is expected to grow at a CAGR of 9.4% during the forecast period. Global factors responsible for the market growth for pharmacy automation devices include the decentralization of pharmacies, the growing need to reduce medication errors, the emergence of automated dispensing machines with scanning technology, and the rising labor costs across the globe.
Know more about this report:请求样本页面
自动化装置提供了某些优点,如最佳药物处方,根据年龄分类,性别有助于减少剂量误差,没有必要的医疗浪费,并通过提高患者安全性的要求,能够适当地供应药物。
Moreover, the emergence of RFID, scanning technology, smart dashboards, and seamless workflow technologies further boosted the market growth for pharmacy automation devices. Such devices also save pharmacists time and labor, thereby, enabling them to spend more time with the patients.
此外,在市场中的关键参与者之间的兼并和收购中,与新产品发布相结合也积极影响药房自动化设备的市场增长。例如,在2020年11月,Omnicell Inc.宣布引入跨国用药管理的最新创新,自动化服务以数字化和简化工作流程。
The innovations also included platform-enabled services to support regulatory compliances, and key intelligence to provide actionable insights to improve the supply chain with a better understanding of medications with improved efficiency and patient outcomes. Such advanced capabilities support healthcare facilities in achieving operational, financial, and clinical goals.
该市场主要根据产品,终用和地理区域进行分段。
By Product |
通过最终使用 |
By Region |
|
|
|
Know more about this report:请求样本页面
2020年,药物分配系统市场分部占全球药房自动化设备行业的最大份额。如此高的份额是由于药物治疗给药错误引起的病态升高。此外,严格的政府政策正在为这些分配系统产生药剂师和医疗机构的压力,以改善患者护理服务。乐动娱乐官网
Furthermore, according to the survey done by the “Pharmacy Purchasing and Products” on automation of pharmacy services, the pharmacies in healthcare facilities are planning to adopt automated dispensing machines, which is expected to drive the market growth for pharmacy automation devices.
Automated compounding systems are expected to witness the fastest market growth over the pharmacy automation devices study period. The rising application of sterile compounding is the most important parameter driving the segment’s fortunes. Moreover, automated robotic compounding conditions empower pharmacists with the concerned tools for improving dosage accuracy, while enabling compliance and reduction in costs.
In 2020, the North America pharmacy automation devices market accounted for over 50% of the global market. Factors contributing to the growth for pharmacy automation devices include technological advancements in workflow systems and reduction in the upfront costs of the automation systems, so it is affordable for small and mid-sized hospitals.
For instance, U.S.-based Duke University Hospital has already implemented Omnicell’s XT series to automate dispensing systems in all their 5 hospitals. Automation has resulted in increased capacity and can accommodate around 30 percent more medications in the given time. Moreover, rising concerns over inadequate inventory management in high volume dispensing machines lead to a high-cost burden among system providers, which ultimately increases the cost of the machine.
亚太地区的药房自动化设备将预计在评估期内实现了利润丰厚的增长率。减少药物治疗误差的需求不断增长,政府之间的过度压力,为该地区的医疗保健设施中的保健设施之间的价格上升,以刺激该地区的药房自动化设备的增长。乐动娱乐官网
例如,根据澳大利亚安全和质量委员会在医疗保健委员会的研究,该国约有3%的录取是由于药物错误。乐动娱乐官网此外,预计发展中国家医疗基础设施的改善将繁荣该地区的药房自动化设备的市场增长。
The prominent players operating in the pharmacy automation devices market are Amerisource Bergen Corporation, Omnicell, Inc., McKesson Corporation, Deenova S.R.L, Accu Chart Plus Healthcare Systems, Inc., Pearson Medical Technologies, LLC, Talyst, LLC, ScriptPro, LLC, Medacist Solutions Group, LLC, Kirby Lester, Cerner Corporation, ARxIUM, CareFusion (Becton Dickinson), Parata Systems, LLC, Swisslog Healthcare, TouchPoint Medical, and Yuyama Co. Ltd.